Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated With Anifrolumab in the Early Access Programs.

Clinical trial NCT06046534 · COMPLETED

Trial details

NCT number: NCT06046534
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Systemic Lupus Erythematosus

Start date: 2023-10-27
Primary completion: 2024-06-10
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.